Is there a need to improve asthma diagnosis in young athletes? by Kippelen, P
Title: Is there a need to improve asthma diagnosis in young athletes? 
 
Pascale Kippelen (PhD) 
Centre for Human Performance, Exercise & Rehabilitation  
College of Health & Life Sciences 
Brunel University London 
Uxbridge, UB8 3PH, UK 
T +44(0)1895 267649 
F +44(0)1895 269769 
Email: pascale.kippelen@brunel.ac.uk 
 
Keywords: asthma, exercise-induced bronchoconstriction, airway hyper-
responsiveness, respiratory symptoms, elite sport, youth athletes, adolescent 
 
Financial disclosure  
Nil 
Acknowledgements 
We thank Drs. Sandra D Anderson and Andrew J Simpson for their input in the 
preparation of the manuscript. 
 
  
Nature and extent of the problem 
Since the late 1990’s, many studies have highlighted that, compared to the general 
population, the prevalence of respiratory disorders is markedly increased in elite sport 
[1]. Notwithstanding other frequent respiratory ailments (e.g., exercise-induced 
laryngeal obstruction or dysfunctional breathing), asthma/airway hyper-
responsiveness (AHR) is the most common chronic medical condition in elite 
athletes; the prevalence in Olympians being 8% [2]. Whilst the majority of data have 
been obtained in athletes aged 18 or over, it has been recognized that up to 50% of 
young elite athletes could suffer from asthma/AHR [3]. 
Athletes the most at risk for asthma/AHR are the ones competing in endurance and 
winter sports, and in swimming [2]. The AHR is thought to reflect injury to the 
epithelium of the lower airways, as a result of the need to condition large volumes of 
air repetitively during training [4]. Inhalation of cold air or of noxious airborne agents 
(allergens, pollutants or chlorination by-products) could contribute and/or amplify the 
damage, and add to the chronicity of the airway inflammation [4].  
In the sporting field, AHR often expresses itself in the form of exercise-induced 
bronchoconstriction (EIB) – i.e., a transient narrowing of the airways that occurs 
during and/or shortly after strenuous exercise – [5]. As such, serial measurements of 
forced expiratory volume in 1 sec (FEV1) – an index of airway caliber – are 
recommended for objective assessment of EIB [6]. The use of respiratory symptoms 
alone is strongly discouraged for diagnostic purpose, in that symptoms are neither 
sufficient, nor essential to confirm the presence of asthma/EIB in young athletes [3,7-
9]. Further, resting spirometry measurements are poor predictors of variable airflow 
obstruction in athletes [10]. 
Reasons for the problem 
Despite the scientific recognition of an increased risk for asthma/AHR in sub-groups 
of young elite athletes, little is currently done to allow early diagnosis, and to improve 
the level of respiratory care delivered to the athletes.  
In the United Kingdom, athletes with suspected EIB (i.e., those experiencing 
respiratory symptoms during and/or shortly after exercise) will typically be assessed 
and treated in primary care. Yet, as demonstrated by Hull and colleagues [11], British 
family practitioners rarely employ the recommended (and most accurate) diagnostic 
tools for EIB (i.e., indirect bronchial provocation challenges with exercise or its 
surrogates [6]). Hence, it does not come as a surprise that almost half of professional 
English soccer players are misdiagnosed for asthma/EIB [12].  
Similarly, in the United States of America, only those patients seen by pulmonologists 
are likely to have a bronchial provocation test and, when they do, it is likely to be 
methacholine [13]. Caution should be taken when interpreting methacholine tests in 
athletes; in winter sports, a positive result can reflect airway epithelial injury rather 
than asthma/EIB, whilst in summer sports, a negative result does not preclude the 
presence of EIB. 
The common practice whereby only symptomatic athletes get referred for a 
respiratory check-up is flawed, in that those young athletes not reporting symptoms 
will never be seen by health professionals. It is however well recognized that a 
significant number of young asymptomatic athletes with no previous history or 
diagnosis of asthma/EIB have AHR [3,7,9]. As with untrained children, this pre-
clinical form of AHR could be a precursor of asthma requiring treatment; hence the 
need for early detection. It remains unclear as to whether asymptomatic athletes i) fail 
to perceive a change in the caliber of their airways, ii) consider their symptoms as a 
‘normal’ response to exercise, or iii) prefer to hide the presence of symptoms 
(probably in fear of being dropped from their team). Minimal difference in the 
perception of bronchoconstriction-related symptoms was recently observed between 
athletes and non-athletes (aged 14 to 35), but worse perception was noticed in the 
young and in males [14]. Since fatal asthma exacerbations during sporting activities 
mainly occur in male athletes aged 10 to 20 years [15], this further emphasizes the 
need for early and accurate diagnosis. 
 
Recommendations 
Many scientists have advocated the use of screening programs for asthma/AHR in 
elite sport. Yet, it is worth reflecting if such a preventive approach is warranted in 
young athletes. A sound screening program is characterized by the following: the 
condition causes a significant burden of suffering; a good screening test is available; 
the preventive intervention or treatment is effective, safe and economically viable.  
 
Acknowledging the burden of suffering 
While the number of deaths directly attributed to sport is fortunately low, the burden 
of the condition is substantial. In sports like swimming, 25 to 50% of young 
competitive athletes could suffer from asthma/AHR [3,7-9]. In soccer and basketball, 
the prevalence in 12-14 year old players has recently been estimated at ~20% [3]. 
However, not all sports are associated with increased risk for asthma/AHR [2]; hence, 
athletes at higher risk should be identified before implementing a screening program. 
 
Asthma/AHR has potential to compromise performance of the high-performing 
athlete. Many athletes worry that their respiratory symptoms [16] or EIB [17] affects 
their performance. While there is limited evidence of a direct impact of asthma/AHR 
on sporting performance in athletes (young or older), data from habitually active 
asthma patients highlight that (steroid-based) anti-inflammatory treatment improves 
exercise pulmonary gas exchange and performance [18]. Over half of children with 
EIB have early onset of airway narrowing during exercise (so called ‘breakthrough’ 
EIB) [19]. It can therefore be speculated that the benefits of anti-inflammatory 
treatment on performance may be greater in the young compared to the older athletes 
(the latter typically developing bronchoconstriction after exercise).  
 
Choosing the appropriate screening test(s) 
A variety of bronchial provocation tests are available to help with the diagnosis of 
asthma/AHR in (young) athletes [5]; all being safe, well accepted, and relatively 
inexpensive. However, the airway response to bronchial challenge may vary with the 
stimulus used, the sport the athlete competes in, the age of the athlete, and the time of 
the year/sporting season when the test is conducted. Hence, there is no ‘gold standard’ 
and a simple ‘one-test-fits-all’ approach cannot be advised.  
With a high ecological validity and a high specificity, exercise is an obvious first, and 
recommended choice [6] for investigation of young athletes with suspected EIB. 
However, if poorly standardized (e.g., if humidity of the inhaled air is not controlled), 
its sensitivity to detect EIB can be significantly reduced. Further, two separate tests 
are often necessary to exclude or diagnose EIB [20]. The highly standardized and 
sensitive eucapnic voluntary hyperpnoea (EVH) test has been recommended for over 
15 years for EIB detection in elite (adult) athletes [21]. However, when conducted in 
young athletes, the target ventilation of 85% of maximum voluntary ventilation may 
need adjustment [3]. Further, as for exercise testing, two EVH tests may be required 
[22]. Due to its high potency, EVH is not recommended in athletes with a history of 
severe clinical asthma; for those, the progressive osmotic challenge tests (i.e., 4.5% 
saline or dry powder mannitol) should be preferred. Because athletes inhale air that is 
completely dry during EVH, and the ventilation achieved during EVH can at times 
exceed ventilation attained in the field, some investigators have argued that EVH 
could give false positive results. To address this issue, in those asymptomatic athletes 
with no history of asthma/EIB but a mild response to EVH (i.e., 10-15% fall in 
FEV1), complementary measures of exhaled nitric oxide may be recommended to 
ascertain the presence of airway inflammation.  
 
Improving treatment 
As for their adult peers [5], the pharmacological treatment of young elite athletes with 
documented asthma/AHR should follow the international recommendations on asthma 
management. However, due to the high heterogeneity in the airway response to beta2-
agonists in children [23], not all young athletes may gain bronchoprotection from this 
class of drugs. Further, due to the high frequency of training (often daily), and to 
avoid possible side-effects of chronic use of inhaled beta2-agonists [23], daily 
preventive treatment with inhaled corticosteroids (ICS) should be considered even in 
those athletes with mild asthma/AHR. Whilst the effectiveness of ICS at controlling 
asthma and reducing AHR is well established, the potential for ICS to alter the natural 
course of asthma in young (and older) athletes remains to be established. Further, one 
difficulty when treating asymptomatic athletes is poor adherence. Education 
(including up-to-date information on anti-doping regulations [24]) should therefore be 




There is a need for better provision of respiratory care in young elite athletes; that 
service should come in the form of improved detection and better management. Thus, 
moving away from symptom-based diagnosis of asthma/EIB and incorporating 
objective testing via indirect bronchial provocation with exercise or its surrogates are 
warranted. To ensure success of new initiatives, the changes should be driven by 
policies; either through anti-doping programs, or mandatory, sport-specific screening 
programs. The implementation of more stringent regulations for inhaled beta2-
agonists usage stands up as an exemplar for a successful (albeit no longer ongoing) 
anti-doping policy [25,26]. Importantly, new policies should be complemented by 
educational programs devised both, for young athletes and for their support staffs 
(including coaches, team doctors, physiotherapists, etc.). It is only when all 
stakeholders fully appraise the nature and extent of the problem that young athletes 
will finally get the level of respiratory care they deserve. 
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